Based on these observations, we hypothesized that reducing TOPBP1 expression could trigger P53 release and enhance the ATM pathway burden, promoting activation of TP53-mediated cell death and inhibition of tumor growth, particularly in cells with high TOPBP1 expression levels. Here, TOPBP1 is linked to neoplasm.